Table 2.
Univariate analysis between successful treatment and unsuccessful treatment in modeling groupa.
| Variables | Total (n = 1,138) | Successful treatment (n = 885) | Unsuccessful treatment (n = 253) | p |
|---|---|---|---|---|
| Gender, n (%) | 0.621 | |||
| Female | 404 (36) | 318 (36) | 86 (34) | |
| Male | 734 (64) | 567 (64) | 167 (66) | |
| Age (years) | 61 (38, 75) | 61 (37, 75) | 64 (41, 74) | 0.409 |
| Creatinine (μmol/L) | 62 (53, 73.75) | 62 (53, 73) | 61 (51, 74) | 0.209 |
| C-reactive protein (mg/L) | 12.41 (2.4, 52.25) | 8.51 (1.8, 34.5) | 73.83 (15.7, 110.6) | < 0.001 |
| White blood cells (10*9/L) | 6.29 (5.1, 8.14) | 6.2 (5.05, 7.9) | 6.82 (5.29, 8.84) | 0.004 |
| Hemoglobin (g/L) | 124.48 ± 20.11 | 127.53 ± 19.1 | 113.81 ± 19.95 | < 0.001 |
| Platelet (10*9/L) | 247 (195, 302) | 244 (195, 296) | 261 (202, 327) | 0.020 |
| Total bilirubin (μmol/L) | 9.4 (7.1, 13) | 9.6 (7.2, 13) | 8.9 (6.8, 12.8) | 0.241 |
| Albumin (g/L) | 36.1 (31.7, 40) | 37.3 (33.6, 40.5) | 30.9 (24.9, 36.6) | < 0.001 |
| Alanine aminotransferase (U/L) | 14 (10, 23) | 14 (10, 24) | 15 (10, 22) | 0.804 |
| Aspartate transaminase (U/L) | 19 (16, 26) | 19 (16, 25) | 20 (15, 27) | 0.939 |
| Total cholesterol (mmol/L) | 3.83 (3.27, 4.48) | 3.85 (3.33, 4.48) | 3.79 (3.09, 4.48) | 0.078 |
| Triglyceride (mmol/L) | 1 (0.76, 1.38) | 1 (0.75, 1.4) | 1.01 (0.76, 1.33) | 0.973 |
| HDL (mmol/L) | 1 (0.82, 1.22) | 1.03 (0.83, 1.24) | 0.92 (0.76, 1.14) | < 0.001 |
| LDL (mmol/L) | 2.25 (1.77, 2.81) | 2.26 (1.79, 2.81) | 2.22 (1.69, 2.79) | 0.254 |
| Smoking, n (%) | 0.596 | |||
| No | 729 (64) | 571 (65) | 158 (62) | |
| Yes | 409 (36) | 314 (35) | 95 (38) | |
| Alcohol consumption, n (%) | 0.236 | |||
| No | 935 (82) | 734 (83) | 201 (79) | |
| Yes | 203 (18) | 151 (17) | 52 (21) | |
| Diabetes, n (%) | < 0.001 | |||
| No | 925 (81) | 771 (87) | 154 (61) | |
| Yes | 213 (19) | 114 (13) | 99 (39) | |
| Tumor, n (%) | 0.017 | |||
| No | 969 (85) | 766 (87) | 203 (80) | |
| Yes | 169 (15) | 119 (13) | 50 (20) | |
| Hypertension, n (%) | 1 | |||
| No | 833 (73) | 648 (73) | 185 (73) | |
| Yes | 305 (27) | 237 (27) | 68 (27) | |
| Liver disease, n (%) | 0.781 | |||
| No | 940 (83) | 733 (83) | 207 (82) | |
| Yes | 198 (17) | 152 (17) | 46 (18) | |
| COPD, n (%) | 0.602 | |||
| No | 1,013 (89) | 785 (89) | 228 (90) | |
| Yes | 125 (11) | 100 (11) | 25 (10) | |
| Pulmonary cavity, n (%) | < 0.001 | |||
| No | 873 (77) | 747 (84) | 126 (50) | |
| Yes | 265 (23) | 138 (16) | 127 (50) | |
| TBTB, n (%) | < 0.001 | |||
| No | 888 (78) | 742 (84) | 146 (58) | |
| Yes | 250 (22) | 143 (16) | 107 (42) | |
| Smear positive, n (%) | 0.888 | |||
| No | 789 (69) | 615 (69) | 174 (69) | |
| Yes | 349 (31) | 270 (31) | 79 (31) |
HDL, High-density lipoprotein cholesterol; LDL, Low-density lipoprotein cholesterol; COPD, Chronic obstructive pulmonary disease. TBTB, Tracheobronchial tuberculosis.